Trulicity 3 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DR26F0WV9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,729
Award facts
- Contract value 100% obligated
- $11,729.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Trulicity 3 mg/0.5 mL pens valued at $11,729.40 with a firm fixed-price structure. This delivery order represents a non-set-aside competitive award and is part of AmerisourceBergen's broader relationship with DLA as a critical pharmaceutical distributor. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, with an ultimate completion date of November 18, 2025. Trulicity is a diabetes management medication commonly used within military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $1 billion global pharmaceutical support vehicle running through December 2026. This prime contract enables AmerisourceBergen to deliver a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's status as a major pharmaceutical distributor and prime contractor under this significant IDC underscores the company's critical role in the federal medical supply chain, particularly for ensuring consistent access to essential medications across Department of Defense healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F0WV9?
SPE2DR26F0WV9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26F0WV9 worth?
The government has obligated $11,729 on SPE2DR26F0WV9.
Is contract SPE2DR26F0WV9 an order under another contract?
Yes. SPE2DR26F0WV9 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F0WV9 competed?
The extent of competition for SPE2DR26F0WV9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award